株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生殖補助医療(ART)の世界市場:2020年~2024年

Global Assisted Reproductive Technology Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 475018
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.96円で換算しております。
生殖補助医療(ART)の世界市場:2020年~2024年 Global Assisted Reproductive Technology Market 2020-2024
出版日: 2020年03月17日 ページ情報: 英文 120 Pages
概要

世界の生殖補助医療(ART)市場は、2020年から2024年の予測期間中に4%のCAGRで成長し、63億1,000万米ドルの規模に達する見込みです。不妊率の上昇と肥満関連の症例の増加が主な成長要因となっています。また、生殖補助医療(ART)に対する意識の高まりによって、更に市場成長が促進される見通しです。

当レポートでは、世界の生殖補助医療(ART)市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2019年
  • 市場の見通し:2019-2024年の予測

ファイブフォース分析

アプリケーション別の市場セグメンテーション

  • 市場セグメンテーション
  • アプリケーション別比較:市場規模と予測2019-2024
  • 不妊治療クリニック
  • 病院
  • その他
  • アプリケーション別の市場機会

顧客情勢

  • 概要

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模と予測2019-2024
  • 欧州
  • 北米
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ地域
  • 主要国
  • 地域別の市場機会

成長要因、課題、および動向

  • 市場成長要因
  • 数量的成長要因-需要主導型成長
  • 数量的成長要因-供給主導型成長
  • 数量的成長要因-外部要因
  • 数量的成長要因-隣接市場での需要シフト
  • 価格上昇要因-インフレ
  • 価格上昇要因-低価格ユニットから高価格ユニットへの移行
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 情勢の革新

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Anecova SA
  • CRITEX GmbH
  • Esco Micro Pte. Ltd
  • 富士フィルムホールディングス
  • INVO Bioscience Inc
  • Merck KGaA
  • Monash IVF Group Ltd.
  • The Cooper Companies Inc.
  • Virtus Health Ltd.
  • Vitrolife AB

付録

目次
Product Code: IRTNTR41430

Technavio has been monitoring the global assisted reproductive technology market 2020-2024 and it is poised to grow by USD 6.31 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. Our reports on global assisted reproductive technology market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in rate of infertility and obesity related cases. In addition, increase in awareness of art is anticipated to boost the growth of the global assisted reproductive technology market 2020-2024 as well.

Market Segmentation

Technavio's ‘ global assisted reproductive technology market 2020-2024 ’ is segmented as below:

Application:

  • Fertility Clinics
  • Hospitals
  • Others

Geographic segmentation

  • APAC
  • Europe
  • MEA
  • North America
  • South America

Key Trends for global assisted reproductive technology market 2020-2024 growth

This study identifies increase in awareness of art as the prime reasons driving the global assisted reproductive technology market 2020-2024 growth during the next few years.

Prominent vendors in global assisted reproductive technology market 2020-2024

We provide a detailed analysis of around 25 vendors operating in the global assisted reproductive technology market 2020-2024, including some of the vendors such as Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd, FUJIFILM Holdings Corp., INVO Bioscience Inc, Merck KGaA, Monash IVF Group Ltd., The Cooper Companies Inc., Virtus Health Ltd. and Vitrolife AB .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Fertility clinics - Market size and forecast 2019-2024
  • Hospitals - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Anecova SA
  • CRITEX GmbH
  • Esco Micro Pte. Ltd
  • FUJIFILM Holdings Corp.
  • INVO Bioscience Inc
  • Merck KGaA
  • Monash IVF Group Ltd.
  • The Cooper Companies Inc.
  • Virtus Health Ltd.
  • Vitrolife AB

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 10.Parent market
  • 13.Market characteristics
  • 15.Offerings of vendors included in the market definition
  • 17.Market segments
  • 22.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 23.Global market: Year-over-year growth 2019 - 2024 (%)
  • 24.Five forces analysis 2019 & 2024
  • 27.Bargaining power of buyers
  • 29.Bargaining power of suppliers
  • 30.Threat of new entrants
  • 31.Threat of substitutes
  • 32.Threat of rivalry
  • 34.Market condition - Five forces 2019
  • 36.Application placement - Market share 2019-2024 (%)
  • 37.Comparison by Application
  • 40.Fertility clinics - Market size and forecast 2019-2024 ($ billion)
  • 41.Fertility clinics - Year-over-year growth 2019-2024 (%)
  • 44.Hospitals - Market size and forecast 2019-2024 ($ billion)
  • 45.Hospitals - Year-over-year growth 2019-2024 (%)
  • 48.Others - Market size and forecast 2019-2024 ($ billion)
  • 49.Others - Year-over-year growth 2019-2024 (%)
  • 51. Market opportunity by Application
  • 52.Customer landscape
  • 54.Market share by geography 2019-2024 (%)
  • 55.Geographic comparison
  • 58.Europe - Market size and forecast 2019-2024 ($ billion)
  • 60.Europe - Year-over-year growth 2019-2024 (%)
  • 63.North America - Market size and forecast 2019-2024 ($ billion)
  • 65.North America - Year-over-year growth 2019-2024 (%)
  • 68.APAC - Market size and forecast 2019-2024 ($ billion)
  • 70.APAC - Year-over-year growth 2019-2024 (%)
  • 73.South America - Market size and forecast 2019-2024 ($ billion)
  • 75.South America - Year-over-year growth 2019-2024 (%)
  • 78.MEA - Market size and forecast 2019-2024 ($ billion)
  • 80.MEA - Year-over-year growth 2019-2024 (%)
  • 82.Key leading countries
  • 84.Market opportunity by geography ($ billion)
  • 85.Impact of drivers and challenges
  • 86.Vendor landscape
  • 88.Landscape disruption
  • 90.Industry risks
  • 92.Vendors covered
  • 94.Market positioning of vendors
  • 96.Anecova SA - Overview
  • 97.Anecova SA - Product and service
  • 98.Anecova SA - Key offerings
  • 99.Anecova SA - Key customers
  • 100.Anecova SA - Segment focus
  • 102.CRITEX GmbH - Overview
  • 103.CRITEX GmbH - Product and service
  • 104.CRITEX GmbH - Key offerings
  • 105.CRITEX GmbH - Key customers
  • 106.CRITEX GmbH - Segment focus
  • 108.Esco Micro Pte. Ltd - Overview
  • 109.Esco Micro Pte. Ltd - Product and service
  • 110.Esco Micro Pte. Ltd - Key offerings
  • 111.Esco Micro Pte. Ltd - Key customers
  • 112.Esco Micro Pte. Ltd - Segment focus
  • 114.FUJIFILM Holdings Corp. - Overview
  • 115.FUJIFILM Holdings Corp. - Business segments
  • 116.FUJIFILM Holdings Corp. - Key offerings
  • 117.FUJIFILM Holdings Corp. - Key customers
  • 118.FUJIFILM Holdings Corp. - Segment focus
  • 120.INVO Bioscience Inc - Overview
  • 121.INVO Bioscience Inc - Product and service
  • 122.INVO Bioscience Inc - Key offerings
  • 123.INVO Bioscience Inc - Key customers
  • 124.INVO Bioscience Inc - Segment focus
  • 126.Merck KGaA - Overview
  • 127.Merck KGaA - Business segments
  • 128.Merck KGaA - Key offerings
  • 129.Merck KGaA - Key customers
  • 130.Merck KGaA - Segment focus
  • 132.Monash IVF Group Ltd. - Overview
  • 133.Monash IVF Group Ltd. - Business segments
  • 134.Monash IVF Group Ltd. - Key offerings
  • 135.Monash IVF Group Ltd. - Key customers
  • 136.Monash IVF Group Ltd. - Segment focus
  • 138.The Cooper Companies Inc. - Overview
  • 139.The Cooper Companies Inc. - Business segments
  • 140.The Cooper Companies Inc. - Key offerings
  • 141.The Cooper Companies Inc. - Key customers
  • 142.The Cooper Companies Inc. - Segment focus
  • 144.Virtus Health Ltd. - Overview
  • 145.Virtus Health Ltd. - Business segments
  • 146.Virtus Health Ltd. - Key offerings
  • 147.Virtus Health Ltd. - Key customers
  • 148.Virtus Health Ltd. - Segment focus
  • 150.Vitrolife AB - Overview
  • 151.Vitrolife AB - Business segments
  • 152.Vitrolife AB - Key offerings
  • 153.Vitrolife AB - Key customers
  • 154.Vitrolife AB - Segment focus
  • 156.Currency conversion rates for US$
  • 157.Research Methodology
  • 158.Validation techniques employed for market sizing
  • 159.Information sources
  • 160. List of abbreviations